MTT GROUP (02350) intends to acquire 100% equity of Hong Kong Wise Wave Technology for HK$87.5 million. Trading will resume on January 2, 2026.
Numis Group (02350) announced that, on December 30, 2025 (after trading hours), the buyer Numis Group Holdings Limited and the seller Wisewave Digital Technology Co., Ltd entered into a share purchase agreement. The seller conditionally agreed to sell the shares for a price of HK$87.5 million, to be paid by issuing and distributing 125 million shares as fully paid shares in accordance with the general authorization. The company has applied to the Stock Exchange to resume trading of the shares on January 2, 2026 (Friday) at 9:00 am.
MTT GROUP (02350) announced that on December 30, 2025 (after trading hours), the buyer MTT GROUP Holdings Limited and the seller Wisewave Digital Technology Co., Ltd entered into a share purchase agreement. The seller conditionally agreed to sell the shares for a price of HK$87.5 million, to be paid by issuing and distributing 125 million shares in accordance with general authorization. The company has applied to the Stock Exchange for the resumption of trading of the shares on January 2, 2026 (Friday) at 9:00 am.
According to the share purchase agreement, the buyer conditionally agreed to purchase the shares from the seller, and the seller conditionally agreed to sell the shares to the buyer, equivalent to approximately 100% equity interest in the target company, Hong Kong Wisewave Technology Limited. The target company is mainly engaged in providing data center solutions, involving computer hardware trading, system integration, and maintenance services.
The acquisition will allow the group to maximize the economic benefits derived from its equity interest in the target company, and create greater shareholder value as the group transforms into a leading provider of artificial intelligence solutions. Considering the group's core business, the acquisition signifies a continuation of the group's growth strategy, seeking to enhance its focus on investments in artificial intelligence through internal nurturing of AI teams and external acquisition of core technology and computing resources.
The company expects to benefit from the acquisition by increasing its equity interest in the target company, gaining immediate access to key computing capabilities and infrastructure, including high-performance GPU/AI chips and algorithm development; leveraging the target company's customer network and market resources in China to accelerate entry into the Chinese artificial intelligence market; establishing partnerships with leading global chip suppliers to enhance supply chain stability; strengthening the target company's technical expertise in artificial intelligence application development and system integration to enhance the group's AI solutions; and enhancing the strategic position and policy advantages of the target company as an operator in Hong Kong to support the development of an international artificial intelligence computing hub.
The board believes that the acquisition will allow the group to quickly enter the smart computing supply chain and access the advanced artificial intelligence infrastructure and resources of the target company, seizing growth opportunities in software, hardware, and artificial intelligence fields, with the potential to enhance the overall performance of the group.
Related Articles

US Stock Market Move | Partial encrypted mining enterprises concept fluctuated and rose. TeraWulf (WULF.US) surged nearly 5%.

US Stock Market Move | Fujian Eastern Red (ORIS.US) Soars Over 25% and Plans to Acquire Controlling Stake in Hubei Daguan Tea Industry Group.

US Stock Market Move | New antiemetic drug Nereus approved by FDA, Vanda Pharmaceuticals Inc. (VNDA.US) surges over 32%
US Stock Market Move | Partial encrypted mining enterprises concept fluctuated and rose. TeraWulf (WULF.US) surged nearly 5%.

US Stock Market Move | Fujian Eastern Red (ORIS.US) Soars Over 25% and Plans to Acquire Controlling Stake in Hubei Daguan Tea Industry Group.

US Stock Market Move | New antiemetic drug Nereus approved by FDA, Vanda Pharmaceuticals Inc. (VNDA.US) surges over 32%






